NYSE: NGVTIngevity Corp Stock
$68.06-0.98 (-1.42%)
Updated Jun 10, 2026
NGVT Price
$68.06
Fair Value Price
N/A
Market Cap
$2.37B
52 Week Low
$39.87
52 Week High
$79.28
P/E
-19.67x
P/B
60.84x
P/S
2.08x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.21B
Earnings
-$127.80M
Gross Margin
39.3%
Operating Margin
-3.93%
Profit Margin
-10.6%
Debt to Equity
41.42
Operating Cash Flow
$304M
Beta
1.25
Next Earnings
Aug 3, 2026
Ex-Dividend
N/A
Next Dividend
N/A
NGVT Overview
Ingevity Corporation manufactures specialty chemicals and activated carbon materials. Its Performance Chemicals segment manufactures chemicals used in processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment offers carbon products used in automobiles. Ingevity was founded in 1964 and is headquartered in North Charleston, SC.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NGVT's potential to beat the market
AStrong Buy
- Stocks with a Zen Rating of Strong Buy (A) had an average return of +32.52% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Chemical
Industry Rating
A
NGVT
Ranked#5 of 51
Ranked#5 of 51
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $5.66 | A | |
| $41.68 | A | |
| $12.75 | A |
Be the first to know about important NGVT news, forecast changes, insider trades & much more!
NGVT News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NGVT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NGVT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NGVT is poor value based on its book value relative to its share price (60.84x), compared to the US Specialty Chemicals industry average (3.63x)
P/B vs Industry Valuation
NGVT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NGVT due diligence checks available for Premium users.
Valuation
NGVT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-19.67x
Industry
8.34x
Market
14.77x
NGVT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
60.84x
Industry
3.63x
NGVT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NGVT's financial health
Profit margin
Revenue
$258.0M
Net Income
$59.8M
Profit Margin
23.2%
NGVT's Earnings (EBIT) of -$47.60M... subscribe to Premium to read more.
Interest Coverage Financials
NGVT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.7B
Liabilities
$1.6B
Debt to equity
41.42
NGVT's short-term assets ($581.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NGVT's long-term liabilities ($1.20B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NGVT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NGVT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.0M
Investing
$106.3M
Financing
-$61.8M
NGVT's operating cash flow ($303.80M)... subscribe to Premium to read more.
Debt Coverage Financials
NGVT vs Specialty Chemical Stocks
Ingevity Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.